Relmada Therapeutics Inc (RLMD) Stock Price, Quote, News & History

RLMDNASDAQ
$4.36
0.030.69%
At close: Aug 31, 5:00 PM EST
$4.36
N/A
After Hours: 4:00 PM EST
Loading...

Key Statistics

Open
$4.31
Close
$4.36
Volume / Avg.
628.24K / 1.70M
Day Range
$4.29 - $4.39
52 Wk Range
0.63 - 8.00
Market Cap
$465.08M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
30
Short Interest
12.83%
Days to Cover
9.35

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-45.99M
Investing Cash Flow (TTM)
-187.82M
Financing Cash Flow (TTM)
243.79M
Free Cash Flow (TTM)
-45.99M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
9.98M

Analyst Trends and Forecast

3
Mar
1
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$244.68M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
2.24
Earnings Yield % (TTM)
-20.99%
Earnings Yield % (FWD)
-13.84%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.94

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$11.33M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$4.31
Close
$4.36
Volume / Avg.
628.24K / 1.70M
Day Range
$4.29 - $4.39
52 Wk Range
0.63 - 8.00
Market Cap
$465.08M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
30
Short Interest
12.83%
Days to Cover
9.35

About

Sector
Health Care
Industry
Pharmaceuticals
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Relmada Therapeutics (RLMD) stock?

A

You can purchase shares of Relmada Therapeutics (NASDAQ:RLMD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Relmada Therapeutics (RLMD) competitors?

Q

What is the forecast, or price target, for Relmada Therapeutics (RLMD) stock?

A

Relmada Therapeutics has a consensus price target of $10.00.

Q

What is the current price for Relmada Therapeutics (RLMD)?

A

The stock price for Relmada Therapeutics (NASDAQ: RLMD) is $4.36 last updated August 31, 2026 at 4:00 PM EDT.

Q

Does Relmada Therapeutics (RLMD) pay a dividend?

A

There are no upcoming dividends for Relmada Therapeutics.

Q

When is Relmada Therapeutics (NASDAQ:RLMD) reporting earnings?

A

Relmada Therapeutics does not have any upcoming earnings scheduled.

Q

Is Relmada Therapeutics (RLMD) going to split?

A

There is no upcoming split for Relmada Therapeutics.

Q

What sector and industry does Relmada Therapeutics (RLMD) operate in?

A

Relmada Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.